Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for BUPRENORPHINE
- Psychopharmacological Treatment of Emotional Distress
- Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl
- Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder
- Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
- Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
- Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
- Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
- Buprenorphine for Cancer Pain
- Transdermal Buprenorphine Patch for Laparoscopic Cholecystectomy
- Buprenorphine, Clonidine, and Dexamethasone on Duration of Brachial Plexus Blocks for Upper Extremity Surgery
- Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)
- Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia
- E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- Sublingual Dexmedetomidine for Treating Opioid Withdrawal
- Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations
- Novel Induction to Buprenorphine/Naloxone
- Open Label Comparison of Injectable Buprenorphine ( Brixadi®) and Naltrexone (Vivitrol®) for Opioid Use Disorder
- Monthly Versus Daily Buprenorphine Formulations for Treatment of Opiate Use Disorder
- High Dose BUP Induction in the Emergency Department (ED)
- KetaMoHydBup: Pharmacokinetic Interaction of S-ketamine, Morphine, Hydromorphone and Buprenorphine
- Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse
- Transversus Abdominis Plane Block With or Without Buprenorphine After Inguinal Hernia Surgery
- Suvorexant for Opioid/Stimulant Co-use
- Evaluating Buspirone to Treat Opioid Withdrawal
- Assessing Optimal XR-Buprenorphine Initiation Points in Jail
- Low-dose Buprenorphine Initiation of Opioid Use Disorder
- Anti-suicidal Effects of Buprenorphine In Depressed Individuals
- True Functional Restoration and Analgesia in Non-Radicular Low Back Pain
- Medication-assisted Treatment for Injecting Drug Users in Vietnam
- Effect of Two Different Doses of Intrathecal Dexmedetomidine as Adjuvant in Elderly Patients Undergoing TURP
- Intravenous Dexmeditomidine for Prevention of Spinal Anesthesia Induced Shivering.
- Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual
- Monthly Injectable BUP for MA Use Disorder (MURB) Trial
- Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)
- Clinical Response to Magnesium Sulfate as an Adjunct in the Anesthesia
- Postpartum MDMA Co-occurring PTSD and OUD
- Olanzapine in OUD Patients
- Extended-release Pharmacotherapy for Opioid Use Disorder
- Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl
- Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
- Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP
- Are Adductor Canal Blocks With Bupivacaine and Added Magnesium Better at Managing Post-operative Pain Than Bupivacaine and Added Buprenorphine in Patients Undergoing Same-day Discharge Total Knee Arthroplasty?
- Serratus Anterior Plane Block With and Without Adjuvants in Video-assisted Thoracoscopy
- Pericapsular Nerve Group Block for Positional Pain and Postoperative Analgesia in Hip Fractures
- Safety of Cannabidiol Given to Subject With Methadone or Buprenorphine
- Cariprazine for Comorbid Cocaine and Opioid Use Didorder
- A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder
- Role of Preoperative Transdermal Buprenorphine Patch in Reducing Postoperative Opioids Consumption in Patients Undergoing Total Knee Arthroplasties - A Randomised Controlled Trial.
- Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
- Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
- Are Superficial Parasternal Intercostal Plane (SPIP) Blocks With Bupivacaine and With or Without Adjuvants Helpful for Post-operative Pain After Coronary Artery Bypass Grafting?
- Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users
- Opioid Use Disorder Treatment Linkage at Sexual Health Clinics Using Buprenorphine
- Cannabidiol on Reward- and Stress-related Neurocognitive Processes in Individuals With Opioid Use Disorder
- The Effect of Buprenorphine Continuation for Patients With Opioid Use Disorder
- Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments
- Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder
- Extended-release Injectable Buprenorphine for Individuals at High Risk of Overdose
- Buprenorphine Induction for Fentanyl Dependent Opioid Users
- Buprenorphine/Naloxone Micro-Dosing for Postoperative Pain Management in Opioid-Tolerant Patients
- Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients
- Feasibility of Pediatric Emergency Department-Initiated Treatment for Adolescents With Opioid Use Disorder
- Cannabidiol in Opioid Use Disorder and Chronic Pain
- HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis
- Virginia Opioid Treatment-Emergency Department
- Providing Suboxone and PrEP Using Telemedicine
- Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- The Effect of Chronic Pain on Delay Discounting in Methadone Patients
- Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)
- Suboxone User Perioperative Early Referral and Enhanced Recovery After Surgery- Orthopaedic Trauma Surgery Population
- Clinical Trials of Multivalent Opioid Vaccine Components
- Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)
- Brain Mechanisms of Pharmacotherapy in Opioid Use Disorder
- A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder
- Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
- Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans
- Extended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use Disorder
- EXHIT ENTRE Comparative Effectiveness Trial
- Biased Opioid Agonists for Treatment of Opioid Withdrawal in OUD
- Buprenorphine Loading in the Emergency Department
- Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses
- Addition of Buprenorphine to Paracervical Block for Pain Control During Osmotic Dilator Insertion
- Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers
- Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder
- Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder
- Overlapping Buprenorphine Initiation (in Opioid Physical Dependence)
- Emergency Department-Initiated Buprenorphine Validation Network Trial
- Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults
- Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal
- Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women
- Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine
- Ketamine for the Treatment of Opioid Use Disorder and Depression
- Adjunctive Effects of Psilocybin and Buprenorphine
- Medication Maintenance Therapy in Community Pharmacy Settings
- Single Ascending Dose Study of ALA-1000
- Opiate Suicide Study in Patients With Major Depression
- A Prospective, Randomized Trial of the Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms
- SUBLOCADE Rapid Initiation Extension Study
- Oxytocin, Stress, Craving, Opioid Use Disorder
- Effects of Dronabinol in Opioid Maintained Patients
- SUBLOCADE Rapid Initiation Study
- Buprenorphine Transdermal Patches Pharmacokinetic Study
- A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain
- Acute Pain Management in Patients on Opioid Replacement Therapy
- Medication Treatment for Opioid Use Disorder in Expectant Mothers
- Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study
- Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study
- Rapid Initiation of Drug Treatment Engagement
- An Open-Label Pilot Study of Sublocade as Treatment for Opiate Use Disorder
- Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD
- Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy
- Community Studies of Long Acting Buprenorphine (CoLAB)
- Medical Management of Sleep Disturbance During Opioid Tapering
- Cannabidiol as Adjunctive Treatment for Opioid Use Disorder
- Clinical Pilot Study in Healthy Men to Characterize the Uptake of Buprenorphine Into and Its Elimination From the Body After Topical Application of Two New Forms of a Skin Patch in Comparison to a Reference Patch
- Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 Hours
- Medication Maintenance Therapy in Community Pharmacy Settings
- Clonidine as Adjunct to Morphine for Neonatal Abstinence Syndrome
- Buprenorphine-Fentanyl Interaction Study
- Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films
- Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology
- Impact of Lofexidine on Stress, Craving and Opioid Use
- Study of a Novel Subcutaneous Depot Formulation of Buprenorphine
- Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals
- Comparison of Three Opioid Detoxification Treatment Regimens
- Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery
- Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode
- Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment
- Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure
- Optimal Treatment of Veterans With PTSD and Comorbid OUD
- XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept
- Improving Office Based Treatment of Opioid Use Disorder With Technology
- HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)
- CBT4CBT for Office Based Buprenorphine
- Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy
- Galantamine and CBT4CBT Pilot
- Assessing the Safety of Buprenorphine in People With Sickle Cell Disease
- Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal
- Interim Buprenorphine Treatment to Bridge Waitlist Delays: Stage II Evaluation
- Buprenorphine Transdermal Patches in Arthroscopic Rotator Cuff Repair
- Facilitating Rapid Naltrexone Initiation
- Gabapentin in the Post-cesarean Pain Management of Buprenorphine Patient
- Maternal Buprenorphine-naloxone Treatment and the Infant
- Efficacy of Buprenorphine on Postoperative Endodontic Analgesia
- Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use
- Intravenous Buprenorphine Versus Morphine for Severe Pain in the Emergency Department
- Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain
- Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075
- A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic
- A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders
- Brain Dopaminergic Signaling in Opioid Use Disorders
- Buprenorphine in the Emergency Department
- High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid
- Onsite Buprenorphine Treatment at Syringe Exchange Programs
- Analgesia Duration of Dexamethasone, Buprenorphine, or Clonidine With Ropivacaine for Interscalene Nerve Block
- Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol
- Opioid Dependence Treatment Therapies in Pregnancy
- Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care
- Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis
- A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse
- Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study
- Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence
- Single Injection Adductor Canal Block Versus Continuous Adductor Canal Infusion for Total Knee Arthroplasty
- Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
- Open-Label Treatment Extension Study
- Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome
- Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction
- Single-dose, Study of RBP-6000 in Opioid Dependent Individuals
- Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper
- Phase II Pharmacokinetics Study of CAM2038
- Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL
- Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence
- Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder
- A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/Naloxone
- A Pilot Text Messaging Intervention to Reduce Smoking in Office-based Buprenorphine and Inpatient Detoxification Patients
- Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology
- Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence
- Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
- A Multiple Dose Opioid Challenge Study
- Medication-Assisted Treatment for Youth With Substance Use Disorders
- Project BEST: Buprenorphine Entry Into Substance Abuse Treatment
- Effects of Low Dose Buprenorphine on Recovery After Hip or Knee Arthroplasty
- Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder
- Improving Treatment Outcomes for Prescription Opioid Dependence
- Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in Malaysia
- An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS Dependence
- An Open Label Study of Oral Minocycline for the Treatment of Patients With Co-occurring Opioid and ATS Dependence
- Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)
- Buprenorphine Group Medical Visits in Primary Care
- Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity
- The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects
- Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder
- Comparing Opium Tincture (OT) With Methadone for Medication-assisted Treatment of Opioid Use Disorder
- Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers
- Ropivacaine With Clonidine For Pediatric Rectus Sheath Blocks- The Magic Combination
- An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion
- Postoperative Analgesia With Buprenorphine for Postoperative Pain Control and Quality of Life After Spinal Surgery
- A Study of the Abuse Liability Potential of ALKS 5461 in Healthy, Non-Dependent, Recreational Opioid Users
- Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal Pain
- Open-Label, Safety Study of Lofexidine
- The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism
- Interim Buprenorphine: Leveraging Medication + Technology to Bridge Delays in Treatment Access
- Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
- Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
- Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone
- Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain
- Bioequivalence and Adhesion Comparison of Buprenorphine Patches
- Efficacy of Pain Treatment on Depression in Patients With Dementia
- Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine
- Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study
- The Effects of Hydromorphone on Responses to Verbal Tasks
- Prolonged Popliteal Fossa Nerve Blockade (Prolonged Pop)
- Buprenorphine Treatment for Opioid Dependence
- Buprenorphine Used With Treatment Resistant Depression in Older Adults
- A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants
- Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine
- Safety and Efficacy Study of NTC-510 to Treat Pain Following Dental Surgery of Third Molars
- A Dose Proportionality and Bioavailability Assessment of Buprenorphine Transdermal Delivery System Second Generation Patches
- Analgesic Response to Opioid Analgesics in Buprenorphine-Maintained Individuals
- Comparison of Different Methods of Pain Control After Cesarean Section for Patients on Buprenorphine or Methadone
- Drug Interaction & Methadone & Buprenorphine
- Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder
- Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population
- Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
- The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers
- Compare the Efficacy and Safety of Norspan to Tramadol/Acetaminophen With Prolonged Postoperative Pain (PASSION)
- Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse
- Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain
- Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain
- Buprenorphine to Improve HIV Care Engagement and Outcomes
- An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or Buprenorphine
- Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults
- Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
- Improving Buprenorphine Detoxification Outcomes With Isradipine
- Nalrexone Facilitated Discontinuation of Buprenorphine
- Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain
- Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film
- Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia
- The Effects of Buprenorphine on Responses to Verbal Tasks
- Effects of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sublingual and Intravenous Buprenorphine
- Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence
- Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects
- Dane County Drug Court Study for Addicted Offenders
- Extended Release Naltrexone for Opioid-Dependent Youth
- Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
- Increased Sensitivity to Pain Caused by Opioids in People Who Have Abused Prescription Opioids
- Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients
- An Interventional Study to Assess the Efficacy and Safety of Buprenorphine in Korean Patients With Spinal Disorders
- RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic La
- Comparison Between Methadone and Morphine for Neonatal Opiate Withdrawal
- Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone
- Long-term Open-Label Safety Study to Evaluate EN3409
- Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects
- Neurocognitive Effects of Opiate Agonist Treatment
- Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin
- Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway
- Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects
- Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)
- Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence
- Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects
- Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines
- An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects
- Buprenorphine Disposition and Cyclosporine
- Norspan Transdermal Patches Study in Osteoarthritis Patients
- Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance
- Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/Naloxone
- Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects
- Duration of Analgesic Effect for Ultrasound Guided Supraclavicular Blocks With the Addition of Buprenorphine to Local Anesthetic Solution
- Transfer of Subjects From Subutex/Suboxone to RBP-6300
- Buprenorphine Disposition and CYP3A
- Fetal and Infant Effects of Maternal Buprenorphine Treatment
- Pupillometry and Pain Thresholds Patients Substituted by Methadone and Buprenorphine
- Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution
- Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients
- The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid Dependence
- HIV, Buprenorphine, and the Criminal Justice System
- Buprenorphine in Acute Renal Colic Pain Management
- Pioglitazone to Treat Opioid Withdrawal Symptoms
- Effects of Voriconazole on the Pharmacokinetics and Pharmacodynamics of Oral Buprenorphine: A Two-phase Cross-over Study in Healthy Subjects
- Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome
- Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Low Back Pain
- Buprenorphine for Treatment Resistant Depression
- Cocaine Use Reduction With Buprenorphine
- A Study to Evaluate the Pharmacokinetic Effect of SCH 503034 (Boceprevir) on Methadone or Buprenorphine/Naloxone Plasma Concentrations (P08123)
- ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD
- Improved Strategies for Outpatient Opioid Detoxification
- Effects of Posaconazole and Voriconazole on the Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine
- ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine
- Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
- Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Require Opioid Analgesia for Acute Moderate to Severe Pain
- Study Assessing the Safety and Therapeutic Effect of Buprenorphine in MDD Patients
- Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain
- Efficacy of Buprenorphine for Treatment of Acute Pain
- Analgesic and Antihyperalgesic Effects of Morphine and Buprenorphine
- Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine
- Norspan Efficacy and Safety Among Elderly Subjects
- Drug-Drug Interaction Study Between Telaprevir and Buprenorphine
- Re-Treatment Study of Probuphine in Opioid Addiction
- Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals
- Study to Assess the PK Profile of NanoBUP Capsules Relative to Suboxone
- Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole
- Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods
- Efficacy and Safety Study of Buprenorphine HCl Buccal Film in Subjects With Low Back Pain
- Medications Development for Drug Abuse Disorders
- Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
- Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions
- Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension Study
- The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) on QT Intervals in Healthy Volunteers
- Safety of BTDS in Subjects With Osteoarthritic (OA) Pain of Hip or Knee: A 6-Month Open-label Extension Phase
- A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals
- Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase
- HIV Risk Reduction in Subutex Injectors in Tbilisi
- Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015
- Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy
- A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction
- Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED)
- Buprenorphine for Late-Life Treatment Resistant Depression
- Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults
- Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults
- Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral Therapy
- Dexamethasone Improves Postoperative Symptoms After Laparoscopic Cholecystectomy
- A Study Comparing Norspan Patch and Oral Tramadol
- Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents
- Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions
- Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal
- Norspan Versus Oxycontin as Postoperative Painkiller to Proximal Extracapsular Fractures of the Femur
- Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME")
- Effects of Buprenorphine on Ulnar Nerve Motor Block
- A Study to Characterize the Pharmacokinetics and Tolerability of Buprenorphine Patches in Children With Moderate to Severe Mouth Pain
- Study of Buprenorphine HCl Buccal Film in the Treatment of Dental Pain
- Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)
- Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain
- Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department
- Disulfiram for Cocaine Abuse in Buprenorphine Treatment
- Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan
- Comparison of Two Dosage Strengths of Transdermal Fentanyl Versus Transdermal Buprenorphine and Placebo in Acute Pain Models in Healthy Volunteers.
- A Single-Dose Study of an Investigational Capsule Formulation of 2 mg/0.5 mg Buprenorphine/Naloxone
- Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
- Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications
- Effectiveness of New Analgesic Strategy Compared to the Usal Antalgic Strategy
- A Double-Blind Study of Buprenorphine Treatment of Acute Suicidality
- Buprenorphine/Raltegravir Pharmacokinetic Interaction Study
- TMC125-TiDP2-C188: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Effect of Multiple-dose TMC125 on Buprenorphine and Norbuprenorphine Administered in HIV-negative Patients on Stable Buprenorphine/Naloxone Maintenance Therapy.
- Study of Probuphine in Patients With Opioid Dependence
- A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence
- Relapse Prevention to Reduce HIV Among Women Prisoners
- Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches
- Buprenorphine Naltrexone-P1 A-Cocaine
- Ability of Aprepitant to Block Opioid Reward in Non-Dependent Opiate Abusers
- Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntron Plus Rebetol (P04408/MK-4031-261)
- Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin in Participants With/Without Substitution Therapy (P05255)
- Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444)
- Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603)
- Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED)
- Effective Treatment for Prescription Opioid Abuse
- Abuse Liability of Suboxone Versus Subutex
- Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial
- Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED)
- Randomized, Double-Blind Cross-Over Trial Of Buprenorphine and Low-Dose Naloxone Versus Buprenorphine
- Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices
- Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain
- Safety and Tolerability of Buprenorphine/Naloxone Film Strips
- Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone
- Clinical Trial of Integrated Treatment for Pain and Opioid Dependence
- Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
- Sublingual Buprenorphine for Chronic Pain
- A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED)
- Buprenorphine for Prisoners
- Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)
- Buprenorphine as a Treatment in Opiate Dependent Pain Patients
- Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee
- Buprenorphine for the Treatment of Neonatal Abstinence Syndrome
- The Discriminative Effects of Tramadol in Humans
- Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain
- Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir
- SSRI and Buprenorphine
- Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care
- Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID 297307)
- Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID: 855509)
- Buprenorphine's Dose Response Curve
- Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence
- Norspan® Patches Versus Tramadol in Subjects With Chronic, Moderate to Severe Osteoarthritis Pain in the Hip Knee and/or Lumbar Spine
- Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement
- HIV Risk Reduction and Drug Abuse Treatment in Iran
- Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations
- Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations
- HIV Risk Reduction and Drug Abuse Treatment in Malaysia
- Treatment of Polydrug-Using Opiate Dependents During Withdrawal
- Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release
- Pharmacokinetics and Pharmacodynamics of Buprenorphine in Healthy Volunteers
- Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Low Back Pain
- Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Osteoarthritic Pain
- Opioid Maintenance Medications Comparison Study
- Buprenorphine in the Treatment of Osteoarthritis (OA) in the Elderly
- Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase.
- The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Back Pain.
- The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain.
- The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.
- Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.
- Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.
- The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain.
- Starting Treatment With Agonist Replacement Therapies (START)
- Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.
- Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee
- Safety and Effectiveness of Buprenorphine Transdermal System in Elderly Subjects With Chronic Pain: Pilot Study.
- Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain
- Safety and Efficacy of Dose Conversion From Vicodin® to Buprenorphine Transdermal System (Butrans™) in Subjects With OA Pain
- Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Osteoarthritis Pain
- Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain
- A Stepwise Strategy Utilizing Buprenorphine and Methadone
- Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients
- Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)
- RCT Comparing Methadone and Buprenorphine in Pregnant Women
- Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users
- Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1
- Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1
- Lofexidine for Inpatient Opiate Detox
- The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration
- Effects of Post-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals
- Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals
- Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids
- Science-Based Treatment for Opioid-Dependent Adolescents
- Neuraxial Pethidine After Lumbar Surgery Trial
- Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users
- Abuse Potential of Buprenorphine/Naloxone
- Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence
- Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
- Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers
- Buprenorphine and Integrated HIV Care Evaluation
- Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1
- Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1
- Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1
- Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1
- Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1
- Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14
- Buprenorphine and Naloxone Combination Study - 10
- Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
- Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2
- Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1
- Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice
- Buprenorphine Maintenance for Opiate Dependence - 6
- Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
- Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
- Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
- Evaluation of Liquid vs. Tablet Buprenorphine - 6
- Comparison of Buprenorphine and Methadone - 3
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-1 - 4
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1
- Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1
- Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2
- Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
- Combining Behavioral Treatment With Agonist Maintenance - 1
- Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
- Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
- Buprenorphine Combination Tablet Feasibility - 1
- A Laboratory Model for Heroin Abuse Medications - 8
- Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
- Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22
- Buprenorphine Pharmacology Related to Addiction Treatment - 21
- Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20
- Buprenorphine Detoxification - BBDVI - 19
- Buprenorphine Pharmacology Related to Addiction Treatment - 18
- Alternate Day Buprenorphine Administration, Phase XII - 17
- Alternate Day Buprenorphine Administration, Phase XI - 16
- Alternate Day Buprenorphine Administration, Phase X - 15
- Alternate Day Buprenorphine Administration, Phase IX - 14
- Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13
- Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12
- Buprenorphine Detox With Two Types of Treatment. BBD II - 11
- Buprenorphine Detox With Two Types of Treatment. BBD I - 10
- Alternate-Day Buprenorphine Administration. Phase VIII - 9
- Alternate-Day Buprenorphine Administration. Phase VII - 8
- Alternate-Day Buprenorphine Administration. Phase VI - 7
- Alternate-Day Buprenorphine. Phase V - 6
- Alternate-Day Buprenorphine Administration. Phase IV - 5
- Alternate-Day Buprenorphine Administration. Phase II - 4
- Alternate-Day Buprenorphine Administration. Phase I - 3
- Gradual Vs. Rapid Buprenorphine Detoxification - 2
- Buprenorphine Dose Alteration Study - 1
- Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
- IV Cocaine Abuse: A Laboratory Model - 3
- Treatment Efficacy for Drug Abuse and AIDS Prevention - 2
- Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
- Buprenorphine Dosing Interval - 5
- Methadone/Buprenorphine Cross-Over Study - 4
- Multicenter Clinical Trial of Buprenorphine - 3
- Clinical Rescue Protocol - 2
- Buprenorphine Maintenance Protocol - 1
- Buprenorphine Maintenance for Opioid Addicts - 3
- Buprenorphine Maintenance for Opioid Addicts - 2
- Buprenorphine Maintenance for Opioid Addicts - 1
- Cocaine Effects in Humans: Physiology and Behavior - 1
Clinical trials list
click for details